Vanta Bioscience Ltd

VANTABIO
Health CareMiscellaneous
SmallcapWith a market cap of ₹67 cr, stock is ranked 2,204
High RiskStock is 4.06x as volatile as Nifty
110.057.95 (-6.74%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareMiscellaneous
SmallcapWith a market cap of ₹67 cr, stock is ranked 2,204
High RiskStock is 4.06x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
149.67
PB RatioPB Ratio
2.75
Dividend YieldDiv. Yield
Sector PESector PE
38.41
Sector PBSector PB
5.14
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The company is a preclinical contract research company. It provides preclinical safety assessment services, assessment services for evaluating the safety of the active pharmaceutical ingredients (API), etc.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020214.0412.6514.2510.070.030.701.020.45
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnNov 29, 2021

Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company | Download

Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company | Download

Company Update 
Announced OnNov 11, 2021

Vanta Bioscience Ltd - 540729 - Expansion Of Scope Of GLP Certification | Download

Vanta Bioscience Ltd - 540729 - Expansion Of Scope Of GLP Certification | Download

Result 
Announced OnNov 11, 2021

Vanta Bioscience Ltd - 540729 - Unaudited Financial Results For Half Year Ended 30.09.2021 | Download

Vanta Bioscience Ltd - 540729 - Unaudited Financial Results For Half Year Ended 30.09.2021 | Download

See all events